Department of Nephrology, The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
Department of Clinical Pharmacy, The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.
Int Urol Nephrol. 2024 Jan;56(1):283-293. doi: 10.1007/s11255-023-03672-4. Epub 2023 Jun 21.
Diabetic nephropathy (DN) is a main cause of end-stage renal disease with high mortality. Circular RNAs (circRNAs) are associated with the pathogenesis of DN. This study aimed to explore the role of circLARP1B in DN.
The levels of circLARP1B, miR-578, TLR4 in DN and high glucose (HG)-treated cells using quantitative real-time PCR. Their relationship was analyzed using dual-luciferase reporter assay. The biological behaviors were assessed by MTT assay, EDU assay, flow cytometry, ELISA, and western blot.
The results indicated that circLARP1B and TLR4 were highly expressed, and miR-578 was low expressed in patients with DN and HG-induced cells. Knockdown of circLARP1B promoted the proliferation and cell cycle, and inhibited pyroptosis and inflammation of HG-induced cells. CircLARP1B is a sponge of miR-578, which targets TLR4. Rescue experiments showed that inhibition of miR-578 reversed the effects of circLARP1B knockdown, while TLR4 reversed the effects of miR-578.
CircLARP1B/miR-578/TLR4 axis suppressed the proliferation, blocked cell cycle at the G0-G1 phase, promoted pyroptosis, and inflammatory factor release of renal mesangial cells induced by HG. The findings suggested that circLARP1B may be a target for the treatment of DN.
糖尿病肾病(DN)是导致终末期肾病和高死亡率的主要原因。环状 RNA(circRNAs)与 DN 的发病机制有关。本研究旨在探讨 circLARP1B 在 DN 中的作用。
采用实时定量 PCR 检测 DN 患者和高糖(HG)处理细胞中 circLARP1B、miR-578 和 TLR4 的水平。采用双荧光素酶报告基因实验分析它们之间的关系。通过 MTT assay、EDU assay、流式细胞术、ELISA 和 Western blot 评估它们的生物学行为。
结果表明,DN 患者和 HG 诱导的细胞中 circLARP1B 和 TLR4 表达水平升高,而 miR-578 表达水平降低。circLARP1B 敲低促进了 HG 诱导的细胞增殖和细胞周期,抑制了细胞焦亡和炎症反应。circLARP1B 是 miR-578 的海绵,可靶向 TLR4。挽救实验表明,miR-578 抑制逆转了 circLARP1B 敲低的作用,而 TLR4 则逆转了 miR-578 的作用。
circLARP1B/miR-578/TLR4 轴抑制了 HG 诱导的肾系膜细胞增殖,使细胞周期阻滞在 G0-G1 期,促进细胞焦亡和炎症因子释放。研究结果表明,circLARP1B 可能是治疗 DN 的一个靶点。